Asia-Pacific’s penicillin G acylase market surges on China’s Shandong mega-scale (60% global 6-APA) and India’s PLI ramps like Lyfius-Qule’s 18,600 MT powerhouse. CRISPR strains, immobilized green tech, and AMR-driven semi-synthetics fuel explosive demand across 200+ API hubs.Chicago, Jan. 06, 2026 (GLOBE NEWSWIRE) — The Asia Pacific penicillin G acylase market was valued at USD 70.01 million in 2025 and is projected to reach USD 131.79 million by 2035, growing at a CAGR of 6.53% from 2026-2035Read More
